ImmuCell Corporation (ICCC) Gross profit 2016–2025
ImmuCell Corporation (ICCC) annual gross profit history from SEC filings — each fiscal year as reported.
$11.4MFY2025 · since FY2016: $5.4M → $11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.4M | +44.1% |
| FY2024 | $7.9M | +105.2% |
| FY2023 | $3.9M | -49.4% |
| FY2022 | $7.6M | -11.6% |
| FY2021 | $8.7M | +26.1% |
| FY2020 | $6.9M | +1.8% |
| FY2019 | $6.7M | +29.8% |
| FY2018 | $5.2M | -0.5% |
| FY2017 | $5.2M | -3.7% |
| FY2016 | $5.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice